{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T08:12:49Z","timestamp":1697443969622},"reference-count":20,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:00:00Z","timestamp":1311897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim\u2002<\/jats:bold> The aim of this study was to know the correlation of patients\u2019 3\u2003months recall on acute dermato\u2010lymphangio\u2010adenitis (ADLA) with anti\u2010streptolysin O (ASO) serology and its application as a tool to know the burden of ADLA in the community.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Fifty\u2010nine lymphoedema (LE) patients and 27 age matched controls were clinically assessed for LE and the occurrence of ADLA during the previous 3\u2003months was obtained by recall. After obtaining the informed consent, 2\u2003mL of venous blood sample was collected and ASO was quantified in Olympus AU400 auto\u2010analyzer.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> When the results were computed as two groups, controls and LE patients with no reported ADLA and LE patients with reported ADLA (by 3\u2003months recall), the ASO positivity and ASO titre was significantly higher in the later group (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05). When the results were computed as three groups, controls with no reported ADLA, LE patients with no reported ADLA and LE patients with reported ADLA, the ASO titre was significantly higher in LE patients reported ADLA (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> As ASO was measured in post\u2010infection phase, we relied on the ASO titre for making conclusion. Patients\u2019 3\u2003months recall on ADLA correlates with the ASO titre and therefore, it could be considered as a tool to measure the burden of ADLA in the community. Multicentre community\u2010based studies are needed to ascertain the findings.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2011.04182.x","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T05:11:30Z","timestamp":1311916290000},"page":"1031-1034","source":"Crossref","is-referenced-by-count":2,"title":["Do the filarial lymphoedema patients\u2019\u20183\u2003months recall\u2019 on acute dermato\u2010lymphangio\u2010adenitis (ADLA) correlate with streptococcal serology?"],"prefix":"10.1111","volume":"26","author":[{"given":"L.J.","family":"De Britto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,29]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"114","article-title":"Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading","volume":"102","author":"Pani SP","year":"1995","journal-title":"Indian J Med Res"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4269\/ajtmh.1996.54.591","article-title":"The epidemiology of acute adenolymphangitis due to lymphatic filariasis in northern Ghana","volume":"54","author":"Gyapong JO","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00090-X"},{"key":"e_1_2_6_5_2","first-page":"5","article-title":"Man\u2010days lost due to repeated attacks of lymphatic filariasis","volume":"7","author":"Sabesan S","year":"1992","journal-title":"Trends in Life Sciences"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01426.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-6-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.57.7"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114747"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07081.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00034983.1999.11813433","article-title":"A double blind placebo controlled study of the efficacy of oral penicillin, Diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphedema caused by brugian filariasis","volume":"93","author":"Shenoy RK","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1179\/000349804225021451"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01442.x"},{"key":"e_1_2_6_14_2","first-page":"66","article-title":"The effectiveness of long\u2010acting penicillin (penidure) in preventing recurrences of dermatolymphangioadenitis(DLA) and controlling skin, deep tissues, and lymph bacterial flora in patients with \u2018filarial\u2019 lymphedema","volume":"38","author":"Olszewski WL","year":"2005","journal-title":"Lymphology"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90666-5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2000072091"},{"key":"e_1_2_6_17_2","first-page":"826","article-title":"Estimation of ASO titre as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis","volume":"4","author":"Suma TK","year":"1997","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_6_18_2","volume-title":"Expert Committee on Filariasis","author":"WHO","year":"1992"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-3-6"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2003.00962.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2006.08.011"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2011.04182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2011.04182.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:07:17Z","timestamp":1697342837000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2011.04182.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,29]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1468-3083.2011.04182.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04182.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,29]]}}}